Please login to the form below

Not currently logged in
Email:
Password:

Pharma and BRIC

This page shows the latest Pharma and BRIC news and features for those working in and with pharma, biotech and healthcare.

Building and delivering market access capabilities in emerging markets

Building and delivering market access capabilities in emerging markets

Within these markets the BRIC countries (Brazil, Russia, India and China) are the dominant players. ... Positioning for growth in BRIC countries is an important strategy for pharma companies.

Latest news

  • All eyes on pharma in Brazil All eyes on pharma in Brazil

    Partnering with big pharma minimises operational risks but, in addition to reduced control over sales, marketing and other processes, royalties rather than sales will diminish sales profitability. ... This article was originally published in the

  • Brazil's healthcare conundrum Brazil's healthcare conundrum

    There is no doubting that Brazil is a major emerging market and one that many big pharma organisations will be keeping a close eye on in the future. ... This article was orginially published in the PME supplement Pharma and BRIC.

  • BRIC 'not delivering' on promises of high growth BRIC 'not delivering' on promises of high growth

    This is according to a new report by analysts Frost &Sullivan, which says that pharma firms expanding into emerging markets like Brazil, Russia, India and China ( BRIC) are realising “ there are ... For more on the impact of the BRIC nations, read

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • The MISTs of time - new emerging markets The MISTs of time - new emerging markets

    Beyond BRIC. It is increasingly clear that the global pharma sector, like many developed industries, is looking outside its traditional and mature markets for sustainable long-term growth. ... This article was originally published in the

  • Intellectual property threats in the BRIC markets Intellectual property threats in the BRIC markets

    For as long as pharma and biotech companies have contemplated doing business in BRIC, there have been questions about intellectual property (IP) risk. ... This article was originally published in the PME supplement Pharma and BRIC.

  • The rise of chronic disease in BRIC markets The rise of chronic disease in BRIC markets

    At present, pharma is steadily putting the building bricks in place, but as the BRIC economies mature and local healthcare systems become embedded, the growth opportunities in these key disease areas ... This article was originally published in the

  • A tailored approach to the BRIC markets A tailored approach to the BRIC markets

    There are increasing examples of pharma companies collaborating with governmental and quasi-governmental institutions in BRIC countries. ... This article was originally published in the PME supplement Pharma and BRIC.

  • Building BRICs: pharma's key emerging markets are becoming giants Building BRICs: pharma's key emerging markets are becoming giants

    Building BRICs: pharma's key emerging markets are becoming giants. The BRIC nations – Brazil, Russia, India and China – for so long the leading lights of the emerging markets movement, may soon ... This article was originally published in the

More from intelligence
Approximately 2 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics